Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.

[1]  R. Pfeiffer,et al.  Biliary tract cancer incidence and trends in the United States by demographic group, 1999‐2013 , 2019, Cancer.

[2]  R. Martino,et al.  Resection for intrahepatic cholangiocellular cancer: new advances. , 2018, Translational gastroenterology and hepatology.

[3]  B. Graubard,et al.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare , 2017, PloS one.

[4]  T. Therneau,et al.  Aspirin use and the risk of cholangiocarcinoma , 2016, Hepatology.

[5]  C. Denlinger,et al.  Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma , 2016, Cancer.

[6]  A. Bergquist,et al.  Epidemiology of cholangiocarcinoma. , 2015, Best practice & research. Clinical gastroenterology.

[7]  H. El‐Serag,et al.  Secular Trends in the Incidence of Cholangiocarcinoma in the USA and the Impact of Misclassification , 2014, Digestive Diseases and Sciences.

[8]  C. la Vecchia,et al.  Trends in alcohol consumption in Europe and their impact on major alcohol-related cancers. , 2014, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[9]  T. Pawlik,et al.  Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis. , 2014, JAMA surgery.

[10]  Y. Ohno,et al.  Long-term Trends in Incidence and Mortality of Intrahepatic and Extrahepatic Bile Duct Cancer in Japan , 2014 .

[11]  Katherine E Henson,et al.  Risk of Suicide After Cancer Diagnosis in England , 2018, JAMA psychiatry.

[12]  C. la Vecchia,et al.  A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  H. Thomas,et al.  Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? , 2012, Journal of hepatology.

[14]  H. El‐Serag,et al.  Risk factors for cholangiocarcinoma , 2011, Hepatology.

[15]  H. El‐Serag,et al.  Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma , 2011, British Journal of Cancer.

[16]  A. Torrice,et al.  Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. , 2010, World journal of gastrointestinal oncology.

[17]  H. El‐Serag,et al.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population‐based study of U.S. veterans , 2009, Hepatology.

[18]  B. Graubard,et al.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[19]  T. O'Brien,et al.  Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. , 2006, Journal of the National Cancer Institute.

[20]  Alan D. Lopez,et al.  Counting the dead and what they died from: an assessment of the global status of cause of death data. , 2005, Bulletin of the World Health Organization.

[21]  B. Choi,et al.  Clonorchiasis and Cholangiocarcinoma: Etiologic Relationship and Imaging Diagnosis , 2004, Clinical Microbiology Reviews.

[22]  T. Patel,et al.  Worldwide trends in mortality from biliary tract malignancies , 2002, BMC Cancer.

[23]  T. Patel.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States , 2001, Hepatology.

[24]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[25]  E. Negri,et al.  Liver cirrhosis and the risk of primary liver cancer , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[26]  C. la Vecchia,et al.  NAFLD and cancer: More cause for concern? , 2017, Journal of hepatology.

[27]  G. Gores,et al.  Classification, diagnosis, and management of cholangiocarcinoma. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.